Clinical Trials Logo

Clinical Trial Summary

This study is designed to find out the effectiveness of combination of ethanol extract of neem leaf, propylene glycol (40%) and salicylic acid (10%) in the treatment of palmar arsenical keratosis.


Clinical Trial Description

Arsenic, a non-essential trace element, is a major water pollutant in Bangladesh. Arsenical keratosis, which occurs in the palm and sole, is a common symptom of arsenicosis. The objective of this study is to find the effectiveness of combination of topical administration of the ethanol extract of leaf of neem (Azadirachta indica), propylene glycol (40%) and salicylic acid (10%) in the treatment of palmar arsenical keratosis. On the basis of inclusion and exclusion criteria, 30 patients of moderate palmar arsenical keratosis will be recruited from an arsenic affected area. They will be divided into two groups: study group and placebo comparator group. Each group consisting of 15 members. Study group will be given combination of ethanol extract of leaf of neem, propylene glycol (40%) and salicylic acid (10%) to apply on palm overnight once daily for 12 weeks. On the other hand placebo comparator group will be given salicylic (10%) acid to apply on palm overnight once daily for 12 weeks. Water and nail samples will be collected before starting recruitment to confirm arsenicosis. After conclusive recruitment of the subjects the objective, nature, purpose and potential risks and benefits of all procedures of the study will be explained in details to the patients and informed written consent will be taken from them. Detail history, clinical examination and photograph (palm) will also be collected. Clinical improvement will be assessed by measuring palmar nodular size on both hands, before starting treatment and after 12 weeks completion of treatment and perception of patients about their improvement. The study will explore the effectiveness of topical use of combination of ethanol extract of neem, propylene glycol and salicylic acid for the treatment of palmar arsenical keratosis. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02352987
Study type Interventional
Source Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Contact
Status Completed
Phase Phase 2
Start date March 2015
Completion date September 2015

See also
  Status Clinical Trial Phase
Completed NCT01748669 - Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis Phase 2
Completed NCT01743066 - Vitamin E Level in Buccal Cells of Arsenicosis Patients N/A
Completed NCT02468518 - Effect of Vitamin E on Skin Aerobic Bacteria in Palmar Arsenical Keratosis Phase 2
Completed NCT02908581 - Effect of Iron and Folic Acid on Skin Fungal Pattern in Patients With Arsenicosis Phase 2
Completed NCT03127657 - Effect of Cock's Comb Extract in the Treatment of Arsenical Skin Lesion Phase 2
Completed NCT01726426 - Modulation of Anaerobic Gut Bacteria of Arsenicosis Patients by Probiotics N/A